chatsaudicam.com

  • Health News

Home ยป (mepolizumab)

Health News 

FDA Approves Nucala (mepolizumab) as the First and Only Biologic Treatment for Hypereosinophilic Syndrome (HES)

09/27/2020 (HES), (mepolizumab), and, Approves, As, Biologic, FDA, first, for, Hypereosinophilic, Nucala, only, syndrome, the, treatment

London UK 25 September 2020 — GlaxoSmithKline plc (GSK) today announced the US Food and Drug Administration (FDA) has approved

Read more
Recent Posts
  • Tanni Grey-Thompson health: Paralympian born with spina bifida – what is the condition?
  • Study finds COVID isolation worsens student diets, inactivity, and alcohol intake
  • The Truth About Green Tea and Weight Loss
  • Breathing easier with a better tracheal stent
  • Rich people more likely to be able to social distance, Johns Hopkins study finds
Copyright © 2021 chatsaudicam.com. All rights reserved.
We and our partners use cookies on this site to improve our service, perform analytics, personalize advertising, measure advertising performance, and remember website preferences.Ok